Page last updated: 2024-10-25

deferoxamine and Staphylococcal Infections

deferoxamine has been researched along with Staphylococcal Infections in 11 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.

Research Excerpts

ExcerptRelevanceReference
"Deferoxamine (DFO) is a siderophore that bacteria use to scavenge iron and could serve as a targeting vector to image bacterial infection where current techniques have critical limitations."1.46 ( Beiraghi, O; Berti, PJ; Blacker, M; Caldwell, D; Ioppolo, JA; Llano, L; Valliant, JF, 2017)
"aureus infection in thigh."1.30Dual radiolabeled liposomes: biodistribution studies and localization of focal sites of infection in rats. ( Awasthi, VD; Goins, B; Klipper, R; Phillips, WT, 1998)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's4 (36.36)18.2507
2000's1 (9.09)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ioppolo, JA1
Caldwell, D1
Beiraghi, O1
Llano, L1
Blacker, M1
Valliant, JF1
Berti, PJ1
Arifin, AJ1
Hannauer, M1
Welch, I1
Heinrichs, DE1
Antunes, AL1
Secchi, C1
Reiter, KC1
Perez, LR1
de Freitas, AL1
D'Azevedo, PA1
van Asbeck, BS1
Marx, JJ1
Struyvenberg, A1
van Kats, JH1
Verhoef, J1
Lindsay, JA1
Aravena-Román, MA1
Riley, TV1
McLean, TW1
Kurth, S1
Gee, B1
Awasthi, VD1
Goins, B1
Klipper, R1
Phillips, WT1
Chandra, R1
Pierno, C1
Braunstein, P1
Boswell, TC1
Wilcox, MH1
Spencer, RC1
Cohen, AR1
Mizanin, J1
Schwartz, E1
Hosking, CS1

Other Studies

11 other studies available for deferoxamine and Staphylococcal Infections

ArticleYear
    Nuclear medicine and biology, 2017, Volume: 52

    Topics: Animals; Biological Transport; Deferoxamine; Diagnostic Imaging; Female; Gallium Radioisotopes; Isot

2017
Deferoxamine mesylate enhances virulence of community-associated methicillin resistant Staphylococcus aureus.
    Microbes and infection, 2014, Volume: 16, Issue:11

    Topics: Abscess; Animal Structures; Animals; Bacterial Load; Deferoxamine; Disease Models, Animal; Female; I

2014
Feasible identification of Staphylococcus epidermidis using desferrioxamine and fosfomycin disks.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2008, Volume: 116, Issue:1

    Topics: Bacterial Typing Techniques; Coagulase; Deferoxamine; Feasibility Studies; Fosfomycin; Humans; Sensi

2008
Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes.
    Blood, 1984, Volume: 63, Issue:3

    Topics: Blood Bactericidal Activity; Deferoxamine; Free Radicals; Humans; Luminescent Measurements; Neutroph

1984
Identification of Staphylococcus epidermidis and Staphylococcus hominis from blood cultures by testing susceptibility to desferrioxamine.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:2

    Topics: Bacteremia; Coagulase; Deferoxamine; Evaluation Studies as Topic; Humans; Microbial Sensitivity Test

1993
Pelvic osteomyelitis in a sickle-cell patient receiving deferoxamine.
    American journal of hematology, 1996, Volume: 53, Issue:4

    Topics: Adolescent; Anemia, Sickle Cell; Chelation Therapy; Deferoxamine; Humans; Ilium; Injections, Subcuta

1996
Dual radiolabeled liposomes: biodistribution studies and localization of focal sites of infection in rats.
    Nuclear medicine and biology, 1998, Volume: 25, Issue:2

    Topics: Animals; Chelating Agents; Deferoxamine; Glutathione; Image Processing, Computer-Assisted; Indium Ra

1998
111In Desferal: a new radiopharmaceutical for abscess detection.
    Radiology, 1978, Volume: 128, Issue:3

    Topics: Abscess; Animals; Deferoxamine; Extremities; Female; Indium; Male; Mice; Rabbits; Radioisotopes; Rad

1978
Susceptibility of coagulase-negative staphylococci to desferrioxamine.
    The Journal of hospital infection, 1991, Volume: 19, Issue:4

    Topics: Deferoxamine; Diagnosis, Differential; Humans; Sensitivity and Specificity; Staphylococcal Infection

1991
Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy.
    The Journal of pediatrics, 1989, Volume: 115, Issue:1

    Topics: Adolescent; Adult; Anemia, Aplastic; Anemia, Sickle Cell; Catheterization, Central Venous; Deferoxam

1989
Radiology in the management of acute iron poisoning.
    The Medical journal of Australia, 1969, Mar-15, Volume: 1, Issue:11

    Topics: Acute Disease; Deferoxamine; Diagnosis, Differential; Gastric Lavage; Humans; Infant; Iron; Lung; Ma

1969